drugset / Trial / NCT06419985

Ketamine HCl Prolonged Release Oral Tablets for CRPS

NCT06419985

Phase 2 Not yet recruiting 65 enrolled University of Southern California
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of Ketamine HCl Prolonged Release (PR) tablets in participants with pain due to complex regional pain syndrome (CRPS). Additionally, this trial will explore the feasibility of the trial design through dosing compliance, clinical instruments for safety and quality of life measurements, and pharmacokinetic profile.

Timeline

Start
2026-07
Primary completion
2028-01
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 80 mg Oral